drugset
drugset / Trial / NCT03693833

CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis.

NCT03693833 ↗

Phase 2 Completed 136 enrolled Aalborg University Hospital Aalborg University · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A randomized, placebo-controlled trial with blinded outcome assessments will be conducted to evaluate the efficacy and safety of CBD in patients with Hand-OA and PsA during a 12-week treatment period.

Timeline

Start
2018-11-28
Primary completion
2021-06-01
Completion
2021-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 10 mg —

Indications

osteoarthritis, hand psoriatic arthritis